Kwarteng, A., Asiedu, E., Sylverken, A., Larbi, A., Mubarik, Y., & Apprey, C. (2021). In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase. Nature Portfolio.
Cita Chicago Style (17a ed.)Kwarteng, Alexander, Ebenezer Asiedu, Augustina Sylverken, Amma Larbi, Yusif Mubarik, y Charles Apprey. In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir as Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase. Nature Portfolio, 2021.
Cita MLA (8a ed.)Kwarteng, Alexander, et al. In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir as Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase. Nature Portfolio, 2021.